Trust in the government and the government-run health care industry is not in a good place, and with the Democrat’s push to use their office of power to force Americans to submit to them, stories of vaccine injuries and death are met by the public with great interest. Today a report from the FDA on the warnings of the Johnson and Johnson vaccine with surely cause new scrutiny on its effectiveness.
“The FDA is expected to announce on Monday that the Johnson & Johnson VACCINE has been linked to a SERIOUS but rare side effect called Guillain-Barré syndrome,” The New York Times reported.
What are we looking at?
Guillain–Barré syndrome (GBS) is a rare neurological disorder in which the body’s immune system mistakenly attacks part of its peripheral nervous system—the network of nerves located outside of the brain and spinal cord.
According to the New York Times article, the Johnson and Johnson Vaccine “can increase the incidence of GBS 3 to 5 times.”
The incidence rate if the disease is 1 in 100,000.
The FDA states that the J&J vaccine can increase the incidence by 3 to 5 times.So that's potentially a 1 in 20,000 chance. pic.twitter.com/NMUxBM0fxF
— Petar Soldo (@Petar_DRC) July 12, 2021
A recent report shows an increase in GBS among other illnesses with the known rise of infectious diseases with a rise in SARS-COv-2, COVID-19:
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated coronavirus disease 2019 (COVID-19) were first reported in December 2019 in Wuhan, China, and rapidly spread around the world.1 Based on data from Johns Hopkins University, as of June 21, 2021, around 178 million cases have been detected, and more than 3.8 million patients have died of COVID-19 globally.2 In Japan, around 786,000 cases have been detected, and 9662 patients have died of COVID-19 as of June 21, 2021.2 COVID-19 is a systemic disorder presenting typically with a fever and respiratory symptoms, but neurological manifestations, such as acute cerebrovascular diseases, seizures, ageusia, anosmia meningitis, and encephalitis, have also been reported.3
Guillain-Barré syndrome (GBS) is relatively rare, but potentially fatal, immune-mediated disease of the peripheral nerves and nerve roots that is usually triggered by infections.4 The incidence of GBS can therefore increase during outbreaks of infectious diseases, as was seen during the Zika virus epidemics.
Yet, there is still pressure from the Democrat-led government to force people to insert the virus by way of the vaccine, into themselves and their children.
Statnews.com reported on Vaccine Hesitancy:
The Food and Drug Administration issuing full approval for two Covid-19 vaccines might not be the game-changer it’s chalked up to be, according to a number of leading public health experts.
Increasingly, some academics and physicians have pushed back on the popular narrative that the FDA is needlessly delaying full approvals for the Pfizer and Moderna coronavirus shots — and spurring vaccine hesitancy by doing so. While full approvals might encourage a handful of Americans to finally get vaccinated, they argue, it’s more important for the agency to make clear that the eventual approvals are motivated by science and not by public pressure.
“I’m not sure that it’s helpful for us to be advocating from the outside, saying: Hey, please approve, please approve,” said Céline Gounder, a physician and epidemiologist who advised President Biden’s transition team on Covid-19 policy. “I think the FDA is aware of the urgency.”
Going down a rabbit hole:
Today’s expected announcement reverses a 2013 report.
Concerns about a connection between flu vaccines and the neurological disorder Guillain-Barré syndrome have been widely publicized since a small but significant association was found after the 1976 swine flu epidemic.
But now a 12-year retrospective study, published in the July 15 issue of Clinical Infectious Diseases, has found no link between the syndrome and the flu vaccine or other vaccines.
Using data from a large California health care system — covering more than 30 million person-years — researchers identified 415 confirmed cases of Guillain-Barré syndrome, which can cause severe weakness and other serious problems. Of these, only 25 had received any vaccine in the six weeks before the onset of the illness. Most had received flu vaccines, but there were also pneumococcal, tetanus, diphtheria, pertussis, typhoid, hepatitis A and hepatitis B vaccinations in the group.
The researchers acknowledge that the rare occurrence of Guillain-Barré limits the statistical power of the study, but they found no significant connection between getting a vaccine and developing Guillain-Barré syndrome.
“We do believe that there was a connection with flu vaccine years ago when they made the vaccine under special circumstances,” said the lead author, Dr. Roger Baxter, co-director of the Kaiser Permanente Vaccine Study Center in Oakland, Calif. “But we haven’t seen it since, and we’re confident we won’t. We think infections are much more likely than vaccines to cause Guillain-Barré.”
